{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:29:11Z","timestamp":1793287751439,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Thrombotic microangiopathies (TMAs) occurring in the postpartum period may be difficult to manage. They present as the combination of mechanical hemolytic anemia and consumption thrombocytopenia due to endothelial dysfunction. The cause of this endothelial aggression can be multiple: thrombocytopenic thrombotic purpura (TTP), HELLP syndrome, antiphospholipid syndrome, atypical hemolytic and uremic syndrome or acute fatty liver of pregnancy. TTP results from a severe deficiency of ADAMTS13, which is a protease cleaving specifically von Willebrand factor chiefly produced by liver cells. There are two main causes, the production of anti-ADAMTS13 auto-antibodies and, more rarely, a genetic deficiency in ADAMTS13. First-line treatment is based on plasma exchange. HELLP syndrome occurs in the third trimester of pregnancy usually in association with preeclampsia and represents a form of TMA characterized by damage to the sinusoidal capillaries of the liver. Prompt delivery is the main treatment. We present a case illustrating the challenges in discriminating between different postpartum TMAs, with a focus on the distinction between TTP and HELLP syndrome. Specifically, we highlight how acute liver failure (ALF) stemming from HELLP may lead to TTP with a spectacular response to plasma exchanges.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case<\/jats:title>\n<jats:p>A 28-year-old, 33\u2009+\u20094\u2009weeks pregnant woman presented with severe preeclampsia complicated by ALF in the setting of partial liver necrosis, disseminated intravascular coagulation, microangiopathic hemolytic anemia and acute kidney injury. Greatly diminished levels of ADAMTS13 (&lt;\u20095%) activity and neurological impairment suggested an initial diagnosis of thrombotic thrombocytopenic purpura (TTP). Therapeutic plasma exchange (TPE) was initiated and complete renal, neurological, hematological and hepatic recovery was observed. Secondary TTP induced by ALF due to HELLP syndrome was the final diagnosis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Our case addresses the overlapping nature of postpartum TMAs and raises the possibility that HELLP-induced ALF may constitute an additional mechanism resulting in TTP, thereby opening a possible indication for TPE.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12882-020-01865-y","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T12:03:08Z","timestamp":1590753788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Severe HELLP syndrome masquerading as thrombocytopenic thrombotic purpura: a case report"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1930-8817","authenticated-orcid":false,"given":"Cyril","family":"Mousseaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9rang\u00e8re S.","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Mohamadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Arrestier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Hertig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Rafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"issue":"21","key":"1865_CR1","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","volume":"129","author":"BS Joly","year":"2017","unstructured":"Joly BS, Coppo P, Veyradier A. Thrombotic thrombocytopenic purpura. Blood. 2017;129(21):2836\u201346.","journal-title":"Blood."},{"issue":"2","key":"1865_CR2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood-2014-02-553131","volume":"124","author":"M Scully","year":"2014","unstructured":"Scully M, Thomas M, Underwood M, Watson H, Langley K, Camilleri RS, et al. Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes. Blood. 2014;124(2):211\u20139.","journal-title":"Blood."},{"issue":"5","key":"1865_CR3","doi-asserted-by":"crossref","first-page":"380.e1","DOI":"10.1016\/j.ajog.2013.01.049","volume":"208","author":"K Wallace","year":"2013","unstructured":"Wallace K, Martin JN, Tam Tam K, Wallukat G, Dechend R, Lamarca B, et al. Seeking the mechanism(s) of action for corticosteroids in HELLP syndrome: SMASH study. Am J Obstet Gynecol. 2013;208(5):380.e1\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"24","key":"1865_CR4","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1182\/blood-2012-02-408914","volume":"119","author":"M Moatti-Cohen","year":"2012","unstructured":"Moatti-Cohen M, Garrec C, Wolf M, Boisseau P, Galicier L, Azoulay E, et al. Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura. Blood. 2012;119(24):5888\u201397.","journal-title":"Blood."},{"issue":"10","key":"1865_CR5","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/jog.13042","volume":"42","author":"M Yoshihara","year":"2016","unstructured":"Yoshihara M, Mayama M, Ukai M, Tano S, Kishigami Y, Oguchi H. Fulminant liver failure resulting from massive hepatic infarction associated with hemolysis, elevated liver enzymes, and low platelets syndrome. J Obstet Gynaecol Res. 2016;42(10):1375\u20138.","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"1865_CR6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/lt.20285","volume":"11","author":"BD Shames","year":"2005","unstructured":"Shames BD, Fernandez LA, Sollinger HW, Chin LT, D\u2019Alessandro AM, Knechtle SJ, et al. Liver transplantation for HELLP syndrome. Liver Transplant Off Publ Am Assoc Study Liver. Dis Int Liver Transplant Soc. 2005;11(2):224\u20138.","journal-title":"Dis Int Liver Transplant Soc"},{"issue":"5","key":"1865_CR7","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.2009070706","volume":"21","author":"F Fakhouri","year":"2010","unstructured":"Fakhouri F, Roumenina L, Provot F, Sall\u00e9e M, Caillard S, Couzi L, et al. Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J Am Soc Nephrol JASN. 2010;21(5):859\u201367.","journal-title":"J Am Soc Nephrol JASN"},{"issue":"9","key":"1865_CR8","first-page":"1029","volume":"88","author":"A Lattuada","year":"2003","unstructured":"Lattuada A, Rossi E, Calzarossa C, Candolfi R, Mannucci PM. Mild to moderate reduction of a von Willebrand factor cleaving protease (ADAMTS-13) in pregnant women with HELLP microangiopathic syndrome. Haematologica. 2003;88(9):1029\u201334.","journal-title":"Haematologica."},{"key":"1865_CR9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2016.03.014","volume":"142","author":"L Sabau","year":"2016","unstructured":"Sabau L, Terriou L, Provot F, Fourrier F, Roumier C, Caron C, et al. Are there any additional mechanisms for haemolysis in HELLP syndrome? Thromb Res. 2016;142:40\u20133.","journal-title":"Thromb Res"},{"issue":"3","key":"1865_CR10","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/bjh.12494","volume":"163","author":"O Pourrat","year":"2013","unstructured":"Pourrat O, Coudroy R, Pierre F. ADAMTS13 deficiency in severe postpartum HELLP syndrome. Br J Haematol. 2013;163(3):409\u201310.","journal-title":"Br J Haematol"},{"issue":"3","key":"1865_CR11","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1182\/blood-2005-01-0152","volume":"106","author":"M Uemura","year":"2005","unstructured":"Uemura M, Tatsumi K, Matsumoto M, Fujimoto M, Matsuyama T, Ishikawa M, et al. Localization of ADAMTS13 to the stellate cells of human liver. Blood. 2005;106(3):922\u20134.","journal-title":"Blood."},{"issue":"2","key":"1865_CR12","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/hep.26372","volume":"58","author":"GCG Hugenholtz","year":"2013","unstructured":"Hugenholtz GCG, Adelmeijer J, Meijers JCM, Porte RJ, Stravitz RT, Lisman T. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome. Hepatol Baltim Md. 2013;58(2):752\u201361.","journal-title":"Hepatol Baltim Md"},{"issue":"2","key":"1865_CR13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2005-03-1087","volume":"107","author":"T Ono","year":"2006","unstructured":"Ono T, Mimuro J, Madoiwa S, Soejima K, Kashiwakura Y, Ishiwata A, et al. Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood. 2006;107(2):528\u201334.","journal-title":"Blood."},{"issue":"6","key":"1865_CR14","doi-asserted-by":"crossref","first-page":"R273","DOI":"10.1186\/cc13115","volume":"17","author":"V Peigne","year":"2013","unstructured":"Peigne V, Azoulay E, Coquet I, Mariotte E, Darmon M, Legendre P, et al. The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulation. Crit Care Lond Engl. 2013;17(6):R273.","journal-title":"Crit Care Lond Engl"},{"issue":"2","key":"1865_CR15","first-page":"194","volume":"52","author":"MA Erkurt","year":"2015","unstructured":"Erkurt MA, Berber I, Berktas HB, Kuku I, Kaya E, Koroglu M, et al. A life-saving therapy in class I HELLP syndrome: therapeutic plasma exchange. Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis. 2015;52(2):194\u20138.","journal-title":"Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis"},{"issue":"1","key":"1865_CR16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2015.08.018","volume":"64","author":"FS Larsen","year":"2016","unstructured":"Larsen FS, Schmidt LE, Bernsmeier C, Rasmussen A, Isoniemi H, Patel VC, et al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol. 2016;64(1):69\u201378.","journal-title":"J Hepatol"},{"issue":"3","key":"1865_CR17","first-page":"580","volume":"131","author":"A Putzu","year":"2019","unstructured":"Putzu A, Schorer R, Lopez-Delgado JC, Cassina T, Landoni G. Blood purification and mortality in Sepsis and septic ShockA systematic review and meta-analysis of randomized trials. Anesthesiol J Am Soc Anesthesiol. 2019;131(3):580\u201393.","journal-title":"Anesthesiol J Am Soc Anesthesiol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01865-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-01865-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01865-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T23:28:46Z","timestamp":1622244526000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-01865-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1865"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-01865-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,29]]},"assertion":[{"value":"6 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of clinical details was obtained from the patient. A copy of the consent form is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AH is an Editorial Board Member of BMC Nephrology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}